Duloxetine Capsule, Delayed Release
Product Images NDC 71335-0402
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71335-0402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Duloxetine Fig10
Duloxetine Fig2
This appears to be a graph displaying the proportion of patients with relapse over time, measured in days from randomization, for two treatments: placebo and Duloxetine. The y-axis ranges from 0 to 10, and the x-axis ranges from 0 to 300 days. The graph shows that a higher proportion of patients on placebo experienced relapse compared to Duloxetine.*
Duloxetine Fig3
Duloxetine Fig4
Duloxetine Fig5
Duloxetine Fig6
Duloxetine Fig8
Duloxetine Fig9
Duloxetine-structure (Duloxetine Structure)
Label Image (Lbl713350402)
This is a description of a package of medication. The package was prepared by Bryant Ranck Prepack and is meant to be compared to Cymbalta 60mg Capsule manufactured by Ajanta Pharma Limited. The package contains 30 units and has an expiration date of MM/YY, with the NDC number 7133504021. The remaining text includes a warning to keep all drugs out of reach of children and to store the medication at room temperature (20°-25°C or 68°-77°F). The last line seems to be a unique identifier and may not provide further useful information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.